Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.

@article{Berger2006AspirinFT,
  title={Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.},
  author={J. Berger and M. Roncaglioni and F. Avanzini and I. Pangrazzi and G. Tognoni and D. Brown},
  journal={JAMA},
  year={2006},
  volume={295 3},
  pages={
          306-13
        }
}
CONTEXT Aspirin therapy reduces the risk of cardiovascular disease in adults who are at increased risk. However, it is unclear if women derive the same benefit as men. OBJECTIVE To determine if the benefits and risks of aspirin treatment in the primary prevention of cardiovascular disease vary by sex. DATA SOURCES AND STUDY SELECTION MEDLINE and the Cochrane Central Register of Controlled Trials databases (1966 to March 2005), bibliographies of retrieved trials, and reports presented at… Expand
536 Citations
Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials
  • 271
  • PDF
Aspirin for Primary Prevention of Cardiovascular Events: Meta-Analysis of Randomized Controlled Trials and Subgroup Analysis by Sex and Diabetes Status
  • 59
  • Highly Influenced
  • PDF
Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis.
  • 135
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 32 REFERENCES
Final report on the aspirin component of the ongoing Physicians' Health Study.
  • Medicine
  • The New England journal of medicine
  • 1989
  • 813
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women
  • 842
  • PDF
Randomised trial of prophylactic daily aspirin in British male doctors
  • 1,100
...
1
2
3
4
...